advertisement
Journal of Ocular Pharmacology and Therapeutics 29
Showing records 1 to 25 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics109471 Ocular Treatments Targeting Separate Prostaglandin Receptors in Mice Exhibit Alterations in Intraocular Pressure and Optic Nerve Lipidome
Arcuri J
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 541-550
109881 The Development of a SIBS Shunt to Treat Glaucoma
Pinchuk L
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 530-540
109539 Activation of Sonic Hedgehog Signaling Pathway Regulates Human Trabecular Meshwork Cell Function
Wang X
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 430-438
109316 Preclinical Pharmacokinetic Profile of Topical Ophthalmic and Intravenous Delivery of QLS-101, a Novel ATP-Sensitive Potassium Channel Opening Ocular Hypotensive Agent
Roy Chowdhury U
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 332-346
109470 Efficacy of Topical 0.05% Cyclosporine A for Ocular Surface Disease Related to Topical Anti-Glaucoma Medications
Kim JG
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 389-397
109725 Intraocular Pressure and Eyedrop Usage Reduction with Intracameral Bimatoprost Implant
Xu W
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 398-403
109539 Activation of Sonic Hedgehog Signaling Pathway Regulates Human Trabecular Meshwork Cell Function
Tan S
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 430-438
109470 Efficacy of Topical 0.05% Cyclosporine A for Ocular Surface Disease Related to Topical Anti-Glaucoma Medications
An JH
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 389-397
109316 Preclinical Pharmacokinetic Profile of Topical Ophthalmic and Intravenous Delivery of QLS-101, a Novel ATP-Sensitive Potassium Channel Opening Ocular Hypotensive Agent
Pervan-Steel CL
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 332-346
109725 Intraocular Pressure and Eyedrop Usage Reduction with Intracameral Bimatoprost Implant
Zhou P
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 398-403
109471 Ocular Treatments Targeting Separate Prostaglandin Receptors in Mice Exhibit Alterations in Intraocular Pressure and Optic Nerve Lipidome
Elbaz A
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 541-550
109725 Intraocular Pressure and Eyedrop Usage Reduction with Intracameral Bimatoprost Implant
Kansara ND
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 398-403
109471 Ocular Treatments Targeting Separate Prostaglandin Receptors in Mice Exhibit Alterations in Intraocular Pressure and Optic Nerve Lipidome
Sharif NA
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 541-550
109316 Preclinical Pharmacokinetic Profile of Topical Ophthalmic and Intravenous Delivery of QLS-101, a Novel ATP-Sensitive Potassium Channel Opening Ocular Hypotensive Agent
Sheeler R
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 332-346
109539 Activation of Sonic Hedgehog Signaling Pathway Regulates Human Trabecular Meshwork Cell Function
Yang S
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 430-438
109470 Efficacy of Topical 0.05% Cyclosporine A for Ocular Surface Disease Related to Topical Anti-Glaucoma Medications
Cho SY
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 389-397
109471 Ocular Treatments Targeting Separate Prostaglandin Receptors in Mice Exhibit Alterations in Intraocular Pressure and Optic Nerve Lipidome
Bhattacharya SK
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 541-550
109316 Preclinical Pharmacokinetic Profile of Topical Ophthalmic and Intravenous Delivery of QLS-101, a Novel ATP-Sensitive Potassium Channel Opening Ocular Hypotensive Agent
Sookdeo HK
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 332-346
109539 Activation of Sonic Hedgehog Signaling Pathway Regulates Human Trabecular Meshwork Cell Function
Liu X
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 430-438
109725 Intraocular Pressure and Eyedrop Usage Reduction with Intracameral Bimatoprost Implant
Frankfort BJ
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 398-403
109470 Efficacy of Topical 0.05% Cyclosporine A for Ocular Surface Disease Related to Topical Anti-Glaucoma Medications
Lee CE
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 389-397
109539 Activation of Sonic Hedgehog Signaling Pathway Regulates Human Trabecular Meshwork Cell Function
Lei J
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 430-438
109316 Preclinical Pharmacokinetic Profile of Topical Ophthalmic and Intravenous Delivery of QLS-101, a Novel ATP-Sensitive Potassium Channel Opening Ocular Hypotensive Agent
Rogers B
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 332-346
109725 Intraocular Pressure and Eyedrop Usage Reduction with Intracameral Bimatoprost Implant
Blieden LS
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 398-403
109470 Efficacy of Topical 0.05% Cyclosporine A for Ocular Surface Disease Related to Topical Anti-Glaucoma Medications
Shim KY; Jun JH
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 389-397
